MAFLD: What Is It?

Houston Methodist

D. Victor

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Neuromodulators: Making the Right Choice for Your Patient

Douglas Drossman

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Goals of Diagnosis and Unmet Needs of Inflammatory Bowel Disease in …

David T. Rubin

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Microbiome Screening in 2024: Ready For Prime Time?

Stanford Medicine

S. Spencer

Hepatitis C Elimination: Obstacles & Opportunities

Houston Methodist

N. Terrault

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

Liver Lessons: Updates in Hepatitis Management Among PWH

UCSF School of Medicine

J. Briggs, J. Price

ACAAI 2024 Insights: Top 10 Pearls for Nourishing Your EoE and FPIES…

ACAAI 2024 Insights

R. Durban

Gut Microbiome Signatures of Brain Aging and Alzheimer's Disease

Texas Alzheimer’s Research and Care Consortium

C. L. Satizabal

Update on Hepatology Literature

UCLA Health

J. Benhammou, C. Wong

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Fatty Liver Disease: When to Refer?

Yale School of Medicine